These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37726681)

  • 1. Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis.
    Chen Q; Mei L; Zhong R; Han P; Wen J; Han X; Zhai L; Zhao L; Li J
    BMC Gastroenterol; 2023 Sep; 23(1):317. PubMed ID: 37726681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
    Ma HY; Dong L; Quan SZ; Li RY; Wang XR
    Ann Palliat Med; 2021 Apr; 10(4):4108-4121. PubMed ID: 33832299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
    Scheiner B; Steininger L; Semmler G; Unger LW; Schwabl P; Bucsics T; Paternostro R; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M
    Liver Int; 2019 Jan; 39(1):127-135. PubMed ID: 30107095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis.
    Takuma Y; Morimoto Y; Takabatake H; Toshikuni N; Tomokuni J; Sahara A; Matsueda K; Yamamoto H
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1782-1790.e4. PubMed ID: 28017842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chitinase-3-like protein 1 in different TCM syndromes and its correlation with liver fibrosis.
    Li H; Xu X; Yi T; Zheng T; Yan T
    Ann Palliat Med; 2022 Jan; 11(1):217-224. PubMed ID: 35144413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B.
    Liu J; Ji Y; Ai H; Ning B; Zhao J; Zhang Y; Dun G
    Korean J Radiol; 2016; 17(3):396-404. PubMed ID: 27134527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis.
    Calvaruso V; Di Marco V; Bavetta MG; Cabibi D; Conte E; Bronte F; Simone F; Burroughs AK; Craxì A
    Aliment Pharmacol Ther; 2015 Mar; 41(5):477-86. PubMed ID: 25580867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Liver Fibrosis Markers in the Prognosis of Liver Cirrhosis: A Prospective Observational Study.
    Qi X; Liu X; Zhang Y; Hou Y; Ren L; Wu C; Chen J; Xia C; Zhao J; Wang D; Zhang Y; Zhang X; Lin H; Wang H; Wang J; Cui Z; Li X; Deng H; Hou F; Peng Y; Wang X; Shao X; Li H; Guo X
    Med Sci Monit; 2016 Aug; 22():2720-30. PubMed ID: 27480906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J; Wang JY; Lu Y
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.
    Calzadilla-Bertot L; Vilar-Gomez E; Torres-Gonzalez A; Socias-Lopez M; Diago M; Adams LA; Romero-Gomez M
    Dig Liver Dis; 2016 Mar; 48(3):283-90. PubMed ID: 26797261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.
    Liao Y; Gong J; Zhou W; Dong H; Liang J; Luo M; Hu B
    J Med Virol; 2019 Apr; 91(4):642-649. PubMed ID: 30537157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis.
    Navadurong H; Thanapirom K; Wejnaruemarn S; Prasoppokakorn T; Chaiteerakij R; Komolmit P; Treeprasertsuk S
    World J Gastroenterol; 2023 Aug; 29(32):4873-4882. PubMed ID: 37701131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
    Yang W; Kim JE; Choi HC; Park MJ; Choi HY; Shin HS; Won JH; Han F; Nickel MD; Cho HC
    Eur Radiol; 2021 Nov; 31(11):8376-8387. PubMed ID: 33782768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.